Skip to content

Unilateral Secondary Breast Reconstruction Using a Muscle-sparing Pedicled Dorsal Flap After Breast Cancer

Unilateral Secondary Breast Reconstruction Using a Muscle-sparing Pedicled Dorsal Flap in Patients With a History of Total Mastectomy for Breast Cancer Single-centre Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06230250
Acronym
RMSU-LDPEM
Enrollment
22
Registered
2024-01-30
Start date
2023-10-01
Completion date
2024-02-28
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient Satisfaction

Brief summary

The use of pedicled dorsal flaps sparing the latissimus dorsi muscle (TDAP and MSLD flap) is a well-described reconstruction method in breast reconstruction after breast cancer. However, little data exists regarding patient satisfaction after this surgery. The main objective of this study was to evaluate patient satisfaction after unilateral total secondary breast reconstruction using a TDAP or MSLD flap.

Interventions

None listed

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE

Inclusion criteria

* Breast reconstruction using a TDAP or MSLD flap between January 1, 2018 and December 31, 2022 * Major * Non opposition * Women with social security number

Exclusion criteria

* Bilateral reconstruction * Partial reconstruction * Immediate reconstruction * Prophylactic reconstruction * Women who did'nt have a breast cancer * Women who don't finish their reconstruction * Women who don't want participate

Design outcomes

Primary

MeasureTime frameDescription
Patient satisfaction5 yearspatient satisfaction by using BREAST questionnaire (0 to 100, and 100 is the best score)

Secondary

MeasureTime frameDescription
Patient characteristics5 yearsPost-operative complications (number of hematoma, number of infection, number of seroma, number of flap lost), duration of the reconstruction (number of days), nature of additional interventions (number of lipofilling, symmetrization (yes or no), prothesis (yes or no))

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026